×
Select Language
mobile header
telelphone
language
Home > Doctors > Dr. Shalini Verma
Dr. Shalini Verma

Dr. Shalini Verma american Oncology Hospitals

Dr. Shalini Verma

Consultant - Medical Oncology

Book an Appointment
Share Profile share

Dr. Shalini Verma is one of the best Medical Oncologists in Sri Ganganagar, known for her comprehensive expertise in diagnosing and managing a wide spectrum of cancers. With a strong foundation in both radiation and medical oncology, she adopts a holistic, evidence-based approach to cancer care.

She is proficient in administering advanced cancer treatments, including chemotherapy, immunotherapy, and targeted therapy, with extensive experience in treating both solid tumors and hematological malignancies. Her approach is deeply patient-centric—blending clinical excellence with empathy, patient education, and strong psychosocial support.

Dr. Shalini has received advanced training from some of India’s most prestigious institutions, including AIIMS Delhi, Tata Memorial Hospital, and KMC Manipal. She has been an active contributor to multidisciplinary tumor boards and clinical research initiatives.

With multiple national and international publications to her credit, she has also been recognized for her contributions with accolades such as the Young Investigator Award at the KSMO International Conference.

Key Areas of Interest:

  • Breast Cancer
  • Lung Cancer
  • Gynecological Malignancies
  • Supportive Oncology

Dr. Shalini Verma remains committed to delivering compassionate, cutting-edge cancer care while continuously advancing her knowledge through research and collaborative practice.

  • Senior Resident at Government Medical College & Hospital - Sector 32, Chandigarh, 2015-2017
  • Research Fellow at Tata Memorial Hospital, Mumbai, 2017-2018
  • Senior Resident at All India Institute Of Medical Sciences (AIIMS), Delhi, 2018-2019
  • Consultant - Radiation Oncology at Dr. Rajendra Prasad Government Medical College, Himachal Pradesh, 2019-2020
  • Assistant Professor - Radiation Oncology at Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Varanasi, Dec 2020 - Feb 2021
  • Consultant - Medical Oncology, Kasturba Medical College, Manipal, 2021-2024
  • MBBS at Dr. Rajendra Prasad Government Medical College, Himachal Pradesh, 2004-2009
  • MD - Radiotherapy, Indira Gandhi Medical College & Hospital, Shimla, 2012-2015
  • DM Medical Oncology from KMC Manipal (2021-2024)
  • Comprehensive Cancer Diagnosis, Staging & Treatment (Solid Tumors & Hematological Malignancies)
  • Chemotherapy, Immunotherapy & Targeted Therapy
  • Management of Breast, Lung, Gynecological & Gastrointestinal Cancers
  • Palliative & Supportive Oncology Care, including Management of Treatment-Related Toxicities
  • Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: A prospective propensity score-matched pair analysis, published in Breast Cancer, September 2019. Patient-reported quality of life with interstitial partial breast brachytherapy and external beam whole breast radiotherapy: a comparison using propensity-score matching, published in Journal of Contemporary Brachytherapy, August 2021.
  • A prospective comparison of subjective and objective assessments of cosmetic outcomes following breast brachytherapy, published in Journal of Clinical Oncology, 2019.
  • A prospective randomized study comparing carboplatin and capecitabine-based chemoradiation versus carboplatin and 5-FU-based chemoradiation in locally advanced head and neck cancer, published in International Journal of Medical and Biomedical Sciences, 2019.
  • Bell’s Palsy in a treated case of breast cancer—a rare presentation of recurrence, published in Indian Journal of Surgical Oncology, 11/01/2020.
  • Primary Broad Ligament Leiomyosarcoma: A rare case report with review of literature, published in Indian Journal of Surgical Oncology, 15/02/2020.
  • Polymorphous low-grade adenocarcinoma of the parotid in a teenager, published in Iranian Journal of Otorhinolaryngology, September 2017.
  • Extraosseous Ewing’s Sarcoma of the parapharyngeal space - a rare entity with review of literature, published in Iranian Journal of Otorhinolaryngology, September 2017.
  • A comparative study to evaluate concurrent chemoradiotherapy versus radiotherapy alone in the management of breast cancer, published in International Journal of Medical and Biomedical Sciences, 2019.
  • To compare the efficacy of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced head and neck cancer (oropharynx/larynx/hypopharynx), published in International Journal of Medical and Biomedical Sciences, 2020.
  • An unusual case of isolated portocaval lymph node metastasis from nasopharyngeal carcinoma, published in Clinics in Oncology, 14/11/2018.
  • A randomized prospective study comparing concomitant chemoradiotherapy using paclitaxel-carboplatin with etoposide-cisplatin in inoperable or non-resectable locally advanced non-small cell lung cancer, published in Clinical Investigation, May 2020.
  • Demographic profile and clinicopathological patterns of colorectal cancer in Sub-Himalayan North India, published in Bengal Journal of Cancer, 2020.
  • Awareness of basics of radiation, dose levels of imaging procedures and radiation safety among nurses in an academic hospital in Himachal Pradesh, India: results of a cross-sectional study, published in ASCB, April 2021.
  • Impact of COVID-19 on cancer patients: an experience from a tertiary care center in Northeast India.
  • Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience, published in ecancer medical science, May 2023.
  • Awarded first prize in NZAROICON for thesis paper in Rohtak, 2014.
  • Awarded travel and accommodation grant in ESMO preceptorship course on Advanced Course on Questions and Answers, September 2019.
  • Awarded travel and accommodation grant in ESMO preceptorship course on Immuno-oncology in Singapore, November 2019.
  • Awarded travel and accommodation grant in ESMO preceptorship course on Breast Cancer in Singapore, November 2019.
  • Presented paper on HRD testing in ovarian cancer at ISMPO Chennai, 2021.
  • Presented poster at NALCCON Conference, 2021 on “The Importance of EGFR Testing in Lung Cancer in the Modern Era: A Commonly Neglected Mutation.”
  • Presented poster at ISMPOCON, 2022.
  • Presented thesis paper on “Comparison of low dose versus standard dose Olanzapine for prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving Adriamycin and Cyclophosphamide chemotherapy” at ICC Conference, 2024.
  • Won the Young Investigator Award at the International KSMO Conference, September 2024.
  • Poster selected at ESMO Asia Congress, Singapore on “Comparison of low dose versus standard dose Olanzapine for prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving Adriamycin and Cyclophosphamide chemotherapy.”

RMC Reg NO.